Mutations and Drugs Portal (MDP): A Database Linking Drug Response Data and Genomic Information

No abstract is available for this paper.

• Publication year

  2016

• Venue

  2016 IEEE 29th International Symposium on Computer-Based Medical Systems (CBMS)

• Publication date

  2016-06-20

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1109/CBMS.2016.10
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells

  2015cited by this paper
• Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.

  2014cited by this paper
• BRCA1-Dependent Translational Regulation in Breast Cancer Cells

  2013cited by this paper
• Global proteome analysis of the NCI-60 cell line panel.

  2013cited by this paper
• The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.

  2013cited by this paper
• An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.

  2013cited by this paper
• Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

  2012cited by this paper
• DNA damage: placing BRCA1 in the proper context.

  2012cited by this paper
• Mass Homozygotes Accumulation in the NCI-60 Cancer Cell Lines As Compared to HapMap Trios, and Relation to Fragile Site Location

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

  2012cited by this paper
• The role of BRAF V600 mutation in melanoma

  2012cited by this paper
• Allele-specific p53 mutant reactivation.

  2012cited by this paper
• Epistatic Relationships in the BRCA1-BRCA2 Pathway

  2011cited by this paper
• mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities

  2010cited by this paper
• CellMiner: a relational database and query tool for the NCI-60 cancer cell lines

  2009cited by this paper
• Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs

  2009cited by this paper
• Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters

  2008cited by this paper
• MicroRNA expression profiles for the NCI-60 cancer cell panel

  2007cited by this paper
• The NCI60 human tumour cell line anticancer drug screen

  2006cited by this paper
• Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel

  2006cited by this paper
• Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

  1989cited by this paper

• No citing papers are available for this paper.